ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SIV Sivota Plc

7.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Sivota Plc LSE:SIV London Ordinary Share GB00BMH30492 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 7.50 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
5.00 10.00 7.50 7.50 7.50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investors, Nec USD 5.62M USD -8.32M USD -0.6613 -0.11 943.88k
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 7.50 GBX

Sivota (SIV) Latest News

Sivota (SIV) Discussions and Chat

Sivota Forums and Chat

Date Time Title Posts
11/1/202307:50Positive Print1,636
10/4/201711:35*** St Ives ***255
21/5/201310:30shares mag interviews boss of st ives2
07/1/201308:23st ives jumps 5 %1
04/1/200713:19PRINTING BACK IN FASHION ????49

Add a New Thread

Sivota (SIV) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Sivota (SIV) Top Chat Posts

Top Posts
Posted at 04/10/2024 09:20 by Sivota Daily Update
Sivota Plc is listed in the Investors, Nec sector of the London Stock Exchange with ticker SIV. The last closing price for Sivota was 7.50p.
Sivota currently has 12,585,000 shares in issue. The market capitalisation of Sivota is £943,875.
Sivota has a price to earnings ratio (PE ratio) of -0.11.
This morning SIV shares opened at 7.50p
Posted at 07/12/2021 09:22 by base7
The anticipated reverse takeover announced today -shares suspended ,placing & large fund raise .When re listed it will be interested to see how The Market rates the new Siv ,whose name will no doubt change in due course
Posted at 02/10/2018 21:13 by bakunin
Just been reading about J Schwan and Solstice.
SIV could well be massively undervalued with this guy at the helm.

eg
hxxps://www.chicagobusiness.com/article/20170718/BLOGS11/170719909/chicago-tech-firm-solstice-gets-a-boost-from-voice-apps-like-alexa
Posted at 02/10/2018 11:30 by edmundshaw
Daft new name. Grabs you so effectively the name had to be explained so we @got it@. This from a marketing company! What's in a name though? Well, about 4% of the company's share capital on today's performance... :-(
Posted at 21/8/2018 12:30 by bookbroker
This is still way undervalued, at the current valuation this ought to be open to an offer, seems very little action in UK market, but SIV is now a US story!
Posted at 16/8/2018 14:23 by miti 1000
From my crude figures, I'd hope debt at year end of 3/8/2018 was around 5.3 million .

Profits for y/e 31/7/2019 are expected to be about 20.5 million.

With deferred considerations for 2018 and 2019 of around 29 million that puts SIV in a pretty strong position in 1 years time with net debt (without any further freehold property sales) of 13.8million with no other debt due.

That looks a strong position and I hope would command a p/e of 9 which should easily equate to a share price of 180p for a fast growing digital media company. The Siv board have done an excellent job to date of turning the company around imo.

Anyone more savvy care to correct my figures ?
Posted at 16/8/2018 14:01 by salchow
scotch broth - which part of the statement implies "accident prone"? A slowdown in one area of healthcare? Businesses don't grow in a linear way. You experience positive surprises one day and have problems to overcome the next and the statement does not imply anything other than good results. The share has doubled since the re-organisation commenced and hopefully over the next few years may double again!
Posted at 05/7/2018 09:53 by bookbroker
Whether or not the market is under-valuing this company or not is subjective, but on the basis of practically reducing their net debt to zero, and now becoming a pure digital advertising play is worthy of a higher price. We know there will be large goodwill writedowns in the next set of results, but these are non-cash essentially, and the onus will be on the remainder of the business. I was pretty abrasive about M. Armitage a year or two back, but what he has done is achieve to clear St. Ives of all of its legacy businesses, and that should be credited. In the process he has shored up the balance sheet, to leave this company in a far stronger position. Surprises me the share price is not higher, but I think shareholders will be rewarded with a decent dividend sooner rather than later!
Posted at 25/6/2018 10:25 by miti 1000
Yes, the disposal and price is inline with broker forecasts .SIV is starting to look cheap imo going forward. Its now a pure digital play on a low PE .Deferred considerations to work through in next 2 years but I'd hope we could get a rerating to 180-200p within the next 18 months if as seems likely digital marketing continues to power ahead.
Posted at 25/6/2018 08:07 by battyliveson
Seems a low multiple on the disposal, but i guess the view must have been that future profits would decline.

At least there seems a clear strategy, and if nothing else it can be easily acquired without a purchaser having to deal with legacy businesses.

I am holding, but would like to see forecasts for the remaining business to get a feel for valuation. Still sense there is a good 30% to 50% upside in share price from here.

Best wishes.

B
Posted at 12/3/2018 13:28 by jatin724
An excellant article!

>
> login to trading account
> login to research account
> help with my account
>
> Home
> Stockwatch: A cheap share on the up
>
> Growth/recovery
> Income
> Long-term growth
> Over-priced?
> The big picture
>
> By Edmond Jackson | Fri, 9th March 2018 - 11:19
> Share this
> Stockwatch: A cheap share on the up
>
> After I cautioned on £60 billion advertising group WPP (WPP) earlier this week, interestingly at the opposite end of the scale in marketing services, £118 millionSt Ives (SIV) has declared very good progress and prospects for its strategic marketing core business.
>
> Interim results to 2 February show adjusted pre-tax profit up 35% to £12.7 million on revenue up 7% to £146.5 million, with strategic marketing now the basis for long-term growth, delivering 23% growth and representing 85% of adjusted operating profit.
>
> In contrast with big advertising groups having issues with multinational clients altering buying patterns for services, St Ives cites its marketing services specialty as robust.
>
> Stockwatch: What to do with this bombed-out blue chip
>
> New client wins include NFU Mutual, Sun Life, Amgem, BMS and Brunswick, and "As a result of an increase in client demand for more integrated solutions, we have continued to drive our collaboration agenda....we continue to focus on the disciplines of digital, data and insight, although strict distinctions are becoming less relevant as clients demand more integrated propositions from us."
>
> It contrasts with the "part-structural, part-cyclical" excuse from WPP for its flat performance just lately; instead affirming how sizable corporate clients continue to spend on development, especially in digital, which accounts for 62% of St Ives' strategic marketing revenues. This is positive both for selective investing in the sector and the wider economic context, though I’d still pay attention to advertising trends as a leading indicator.
> Interim progress helps full-year forecasts
>
> Before these 7 March results, the consensus expectation (see table) for pre-tax profit rising over £24 million and earnings per share (EPS) over 12p looked demanding.
>
> Admittedly, the outlook statement is a bit convoluted and doesn't mention the full year. New projects won from existing and new clients, seem bullish for strategic marketing, "however we recognise the need to continue to address the effect that our legacy businesses are having on the group’s overall performance..."
>
> Long-term followers will know they have been an Achilles heel involving nasty changes, however, in books printing (26% of interim revenue, 10% down on the prior period due to a contract loss) "we are continuing to take decisive action to ensure the cost base reflects anticipated volumes" and on 5 March a "significant" part of the marketing activation activities - four businesses - were sold for £6 million, having struck a £4.4 million loss on £106.3 million revenue in the year to 28 July 2017.
>
> This is large-format printing and other services, and the sale "significantly reduces the group's exposure to the structurally challenged, commoditised print markets and the risk of further, potentially significant restructuring costs."
>
> A chief risk to 2018-19 forecasts is, therefore, the remaining print-related businesses offsetting good performance from strategic marketing, if the UK economy eases under Brexit uncertainties and higher interest rates.
>
> Yet this could be discounted by a forward price/earnings (PE) multiple of about 6 times, admittedly with de-rated dividend expectations providing little downside support, given a 2.4% yield at the current share price around 82p.
>
> The interim dividend is maintained at 0.65p per share, but the total dividend dropped from 7.8p in respect of the 2016 year to 1.95p in 2017. Mind that tables like the one shown cite payments actually made in a period, which can lag a change in policy.
>
> Anyway, and with goodwill/intangibles representing 192% of net assets as of 2 February 2018, intrinsic value very much relies on earnings.
>
> Adjusted versus statutory figures in the latest release thwart a comparison of operating margin but, looking back to the March 2017 interims, the margin is up from 5.8% to 9.7% on an adjusted basis.
> Balance sheet issues
>
> The next key question for medium-term prospects is to what extent gearing and other balance sheet issues could weigh.
>
> Long-term debt is down from £88.9 million to £63.7 million (there being no short-term bank debt) versus £21.4 million cash.
>
> However, a £26.6 million deferred consideration payable demands a cautious view of near-term financial pressures than a net debt measure of £34.2 million implies.
>
> Last October's 2017 accounts had indicated £29 million cash and £7 million shares due paid in the next two years, with £20.5 million cash due 2018 and £8.5 million due 2019, all this being over the £26.6 million deferred consideration if you just look at the interim balance sheet.
>
> An interim finance expense of £1.4 million was covered nearly 10 times by operating profit. Ideally, this would be lower though should not weigh on the balance sheet, near-term.
>
> You could take quite a negative view of all this if deferred consideration payments soak up cash in the relative near term, and clients proceed to cut marketing budgets in a general slowdown, which also coincides with interest rates having to rise to contain inflation. That would be a worse-case "UK stagflation" scenario.
>
> Meanwhile, cash generated from operations is up 23% to £23.1 million despite a comparative slip at the net level as a prior tax credit normalising to a tax payment. Priority to manage liabilities is shown by the cash flow statement: dividend payments down from £7.8 million to £1.9 million, like-for-like, while a £5 million decrease in bank loans rose to a £15.5 million decrease this time.
>
> Otherwise, £60.6 million trade receivable versus £59.0 million trade payables looks fair, reported profit is not being enhanced by late payments. And despite a £15.8 million pension fund deficit, it's down 15% like-for-like.
> St Ives - financial summary Consensus estimates
> year ended 31 Jul 2013 2014 2015 2016 2017 2018 2019
>
> Turnover (£ million) 323 331 345 368 393
> IFRS3 pre-tax profit (£m) 5.5 11.9 8.7 -5.7 -44.1
> Normalised pre-tax profit (£m) 15.9 14.7 14.8 19.4 12.7 24.3 25.5
> Operating margin (%) 5.2 5.0 5.1 6.1 3.9
> IFRS3 earnings/share (p) 3.6 8.3 4.2 -5.9 -30.4
> Normalised earnings/share (p) 12.0 10.5 8.9 12.4 9.4 12.1 13.3
> Earnings per share growth (%) 11.6 -12.6 -15.6 39.6 -24.2 28.9 9.9
> Price/earnings multiple (x) 8.7 6.8 6.2
> Historic annual average P/E (x) 17.8 18.6 16.3 6.4 7.8
> Cash flow/share (p) 26.1 21.2 20.8 10.6 19.0
> Capex/share (p) 5.2 8.5 1.0 3.1 -5.8
> Dividend per share (p) 6.0 6.7 5.0 7.9 6.1 2.0 2.0
> Dividend yield (%) 7.4 2.4 2.4
> Covered by earnings (x) 2.1 1.6 1.2 1.6 1.5 6.2 6.8
> Net tangible assets per share (p) 20.3 -18.3 -38.5 56.5 38.1
>
> Source: Company REFS Past performance is not a guide to future performance
> Broadly a UK but also US business
>
> While the 2018 interims don't give a latest geographic breakdown, the 2017 accounts report showed revenue as 83% UK-derived, 13% US and 4% rest-of-world. If anything, UK majority revenues are likely reducing with the latest disposals; the operating review cites for strategic marketing, "growth and improved profitability in our US businesses, with the new office in San Francisco quickly building a strong presence in the technology sector."
>
> Healthcare consulting has also expanded abroad, especially in the US. Thus, St Ives is not exposed to potential issues arising from whatever trade agreement (or not) is struck with the EU, like the big advertising groups. If the UK economy does slow as a result of Brexit, this group's clients are generally big firms/organisations, and likely more resilient to marketing cuts than smaller ones.
>
> Admittedly, as a turnaround stock, St Ives has needed trading. I first drew attention near 90p in October 2012, on an historic PE of 5 and prospective yield of 7% covered 2.5 times; the price had shot up to 225p a year or so later; and in March 2015 I suggested risk appeared to weigh on the upside at 177p.
>
> Stock to Watch: St Ives
>
> The share price hit 247p a further year on, but a downturn started from April 2016 as various large projects e.g. in books printing got cancelled and deferred. Challenges persisted for the grocery-oriented marketing activation side and the stock was down to 37.5p in mid-2017.
> Much more focused, on a growth segment
>
> Despite the "Clays" books printing side remaining, it is a market leader which ought to help a sale. Meanwhile, the strategic marketing businesses look in strongest shape and St Ives relatively most-focused, than at any time I've covered the group.
>
> Barring a UK recession, at about 82p the stock, therefore, offers scope to re-rate - likewise dividends - as the deferred considerations are managed through. The operations could also prove a useful integration for another marketing services group, to bid while market price is low. Accumulate.
Sivota share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock